Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Industrial Promotion Services (IPS) is the industrial and infrastructure development arm of the Aga Khan Fund for Economic Development (AKFED), operating extensively across East and West Africa. In the healthcare sector, IPS is a major manufacturer and distributor of essential medicines through its subsidiaries, such as Kampala Pharmaceutical Industries (KPI) and Abacus Parenteral Drugs Limited (APDL). The company focuses on producing high-quality generic pharmaceuticals, including anti-malarials, antibiotics, and intravenous fluids, to improve regional self-sufficiency and access to affordable healthcare. IPS facilities are designed to meet international standards, including WHO Good Manufacturing Practice (GMP) certifications, positioning the group as a critical player in the African pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Industrial Promotion Services.